BeyondSpring Inc. Cash
BeyondSpring Inc. (BYSI) had Cash of $24.68 million as of 2019-09-30, per its 6-K filed 2019-12-18.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash and Cash Equivalent
us-gaap:Cash · last filed 2019-12-18
- 2019-09-30: Cash $24.68M.
- 2019-06-30: Cash $674.00K.
- 2019-03-31: Cash $1.96M.
- 2018-12-31: Cash $3.89M.
| Period end | Cash |
|---|---|
| 2019-09-30 | $24.68M 6-K · filed 2019-12-18 |
| 2019-06-30 | $674.00K 6-K · filed 2019-09-18 |
| 2019-03-31 | $1.96M 6-K · filed 2019-07-10 |
| 2018-12-31 | $3.89M 6-K · filed 2019-09-18 |
| 2018-06-30 | $19.41M 6-K · filed 2018-10-23 |
| 2018-03-31 | $18.35M 6-K · filed 2018-06-21 |
| 2017-12-31 | $27.48M 20-F · filed 2019-04-30 |
| 2017-09-30 | $37.72M 6-K · filed 2017-11-09 |
| 2017-06-30 | $48.98M 6-K · filed 2017-08-21 |
| 2017-03-31 | $54.56M 6-K · filed 2017-05-22 |
| 2016-12-31 | $11.69M 20-F · filed 2018-04-03 |
| 2015-12-31 | $10.82M 20-F · filed 2017-04-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |